Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM8J5H1)

Drug Name

PRLX93936 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Voltage-dependent anion-selective channel 3 (VDAC3)	TTT48SQ	VDAC3_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01695590) Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma. U.S. National Institutes of Health.
2	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.